Why CAMP4?
Leadership
About Our Name
RAP Platform
RNA Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Investors
Newsroom
Join the Adventure
Recent News
October 11, 2024
Camp4 CEO credits CFO, investors’ ‘risk appetite’ for IPO
Read More
Contact Us
Privacy Policy
Terms of Use
Menu
Newsroom
Views and missives from the frontier
All
Perspectives
In the News
Videos
February 21, 2024
Perspectives
Sizing up induced microglia-like cells as neurodegenerative disease models: a Q&A with Gokul Ramaswami, Ph.D.
January 23, 2024
Perspectives
JMnorm: A New Computational Method to Normalize Epigenetic Data for Drug Discovery
December 13, 2023
Perspectives
Shedding light on the dark side of the genome: CAMP4’s approach to targeting regRNA in genetic diseases
July 5, 2023
Perspectives
Intersections in transcription: How an academic study validates CAMP4’s platform
July 7, 2022
Perspectives
EPIC proportions of discovery: CAMP4’s AI model for identifying regRNA targets
Media Contact:
PR@camp4tx.com
Top
